A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

Phase 1 Completed 6 enrolled Impact Therapeutics, Inc.

NaSingle-groupOpen-labelOther

Summary

A Phase I, Open-label Study of Absorption-Distribution-Metabolism-Excretion (ADME) of \[14C\]IMP4297 Following a Single Oral Dose to China Healthy Male Subjects

Timeline

Start: 2021-10-09
Primary completion: 2021-12-06
Completion: 2021-12-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	IMP4297	Unknown	100 mg	Oral

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

Summary

Timeline

Drugs

Indications